CCBT Private Equity logo

CCBT Private Equity

Asia, Beijing, China, Beijing

Description

CCBT Private Equity is a corporate venture capital firm of CCB Trust.

Investor Profile

CCBT Private Equity has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CCBT Private Equity frequently co-invest with?

Yuexiu Group
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
B
Asia, Beijing, China, Beijing
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
Dingxin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does CCBT Private Equity often collaborate with?

SI
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by CCBT Private Equity?

IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 14, 2022